Active pharmaceutical ingredient-incorporated supramolecular materials as antibacterial agents

Area of Science:

• Materials Science
• Pharmacology
• Microbiology

Background:

• Metronidazole is an active pharmaceutical ingredient (API) used to treat anaerobic bacterial infections.
• Supramolecular materials offer novel drug delivery systems with potential for enhanced therapeutic efficacy.
• Developing targeted antibacterial agents with reduced host toxicity is a significant challenge in medicine.

Purpose of the Study:

• To synthesize and characterize novel supramolecular materials incorporating the API metronidazole.
• To evaluate the antibacterial activity of these metronidazole-based supramolecular materials against the anaerobic bacterium *P. gingivalis*.
• To assess the cytotoxicity of the developed materials towards mammalian fibroblast cells.

Main Methods:

• Synthesis of pyridyl-carbamate and their N-oxide derivatives as supramolecular material scaffolds.
• Incorporation of metronidazole into the designed supramolecular structures.
• In vitro testing of antibacterial efficacy against *P. gingivalis*.
• Cytotoxicity assays using mammalian fibroblast cell lines.

Main Results:

• The metronidazole-incorporated supramolecular materials, including N-oxide derivatives, demonstrated significant antibacterial activity against *P. gingivalis*.
• The developed supramolecular materials exhibited no observable toxicity to mammalian fibroblast cells.
• The findings suggest successful integration and functional retention of metronidazole within the supramolecular framework.

Conclusions:

• API-incorporated supramolecular materials based on pyridyl-carbamate derivatives represent a promising strategy for developing effective antibacterial agents.
• The non-toxic nature of these materials in mammalian cells highlights their potential for therapeutic applications.
• Further research into these supramolecular systems could lead to advanced treatments for anaerobic bacterial infections.